New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 15, 2014
09:16 EDTAAN, MS, POT, JNJ, PESI, INFY, ZBRA, KO, HALO, BHP, MSIOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Coca-Cola (KO), up 2.2%... Johnson & Johnson (JNJ), up 2.1%. ALSO HIGHER: Zebra Technologies (ZBRA), up 5.5% after agreeing to acquire Motorola Solution's (MSI) enterprise unit for $3.45B. Motorola Solutions shares are up 3.5% following the news... Halozyme (HALO), up 8.5% after initiated with Buy rating at Citigroup... Potash (POT), up 2.3% after Globe & Mail says the company is speculated to be targeted again by BHP Billiton (BHP)... Morgan Stanley (MS), up 2% after upgraded at BofA Merrill Lynch. DOWN AFTER EARNINGS: Infosys (INFY), down 2.5%... Perma-fix (PESI), down 8.9%. ALSO LOWER: Aaron's (AAN), down 5% after cuttings Q1 EPS and revenue guidance, acquiring Progressive Finance Holdings for $700M, and rejecting Vintage Capital's takeover offer.
News For KO;JNJ;MSI;ZBRA;POT;BHP;INFY;MS;HALO;PESI;AAN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 18, 2014
13:28 EDTBHPIron ore, steel stocks lower after iron ore prices, China home prices decline
Subscribe for More Information
12:50 EDTINFYInfosys BPO unit fires CFO, unit CEO resigns
Subscribe for More Information
10:41 EDTPOTFertilizer names rise after Uralkali suspends work at mine
Subscribe for More Information
10:16 EDTPOTPotash continues recent recovery, levels to watch
Subscribe for More Information
09:02 EDTMSMorgan Stanley Wealth Management forms Global Sports & Entertainment unit
Subscribe for More Information
November 17, 2014
07:16 EDTJNJMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 14, 2014
16:21 EDTJNJOn The Fly: Closing Wrap
Subscribe for More Information
14:53 EDTJNJCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
November 13, 2014
16:28 EDTJNJGeron announces global strategic collaboration with Janssen Biotech
Geron (GERN) announced that the company has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, a Johnson & Johnson (JNJ) company, to develop and commercialize, imetelstat, Geron's telomerase inhibitor product candidate, for oncology, including hematologic malignancies, and other human therapeutics uses. Imetelstat is a modified oligonucleotide that is currently in early phase clinical development for myelofibrosis, or MF, and may have activity in other hematologic myeloid malignancies such as myelodysplastic syndrome, or MDS, and acute myelogenous leukemia, or AML. Under the terms of the agreement, Geron will receive an initial payment of $35M due after the applicable waiting periods under the Hart-Scott Rodino Act and is eligible to receive additional payments up to a potential total of $900M for the achievement of development, regulatory and commercial milestones, as well as royalties on worldwide net sales. Certain regulatory, development, manufacturing and promotional activities will be managed through a joint governance structure, with Janssen responsible for operational implementation of these activities. All sales will be booked by Janssen.
12:26 EDTPOTKoch Industries reports new Colfax stake in quarterly filing
Subscribe for More Information
11:54 EDTJNJJanssen announces FDA approved sNDA for INVEGA SUSTENNA
Subscribe for More Information
10:44 EDTJNJMallinckrodt news on generic Concerta positive for Actavis, says BMO Capital
Subscribe for More Information
08:52 EDTINFYInfosys among suitors for Airbus' CIMPA unit, Economic Times says
Infosys (INFY) is among the suitors looking to acquire CIMPA, the engineering services unit of Airbus (EADSY), said Economic Times, citing people familiar with the matter, who added that Infosys could also get a revenue assurance from Airbus as part of a deal. Reference Link
November 12, 2014
10:46 EDTMSMorgan Stanley's Kelleher says Europe needs viable securitization framework
Subscribe for More Information
10:37 EDTMSMorgan Stanley's Kelleher says firm is negative on Europe for growth
The company's President, Institutional securities Colm Kelleher is speaking at the BofA Financial Services Conference.
10:25 EDTKOSABMiller, Coca-Cola to form new company in Africa, Sky News reports
Mark Kleinman of Sky News tweeted, "SABMiller and Coca-Cola to announce formation of new company in Africa later this week, consolidating existing operations, I'm told."
08:12 EDTPESISeeThruEquity to hold a conference
Subscribe for More Information
07:28 EDTMSBofA/Merrill to hold a conference
Subscribe for More Information
05:59 EDTBHPBHP Billiton says Nickel West to remain in portfolio as non-core asset
Subscribe for More Information
November 11, 2014
09:18 EDTHALOHalozyme price target lowered to $10 from $12 at JMP Securities
JMP Securities cut its price target on Halozyme after the company said it intends to explore partnerships and/or strategic alternatives for the Hylenex program in diabetes. The firm removed the diabetes program from its valuation due to uncertainty. It reiterates an Outperform rating on the shares.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use